Catalyst Repository | Twist Bioscience Corporation Common Stock

Twist Bioscience Corporation Common Stock

(NASDAQ:TWST)

Description

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has a collaboration agreements with ImmunoPrecise Antibodies Ltd.; Victorian Clinical Genetic Services; and Kyowa Kirin Pharmaceutical Research, Inc. Twist Bioscience Corporation was founded in 2013 and is headquartered in South San Francisco, California.

TWST Overview

None
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Previous Close
$24.7800
Previous Close Volume
959970